Description
Stratus OCT incorporates optical coherence tomography technology to provide comprehensive imaging and measurement of glaucoma and retinal disease. Stratus OCT is the gold standard in-vivo imaging device for the posterior segment and offers proven reproducibility for disease management. Stratus provides real-time cross-sectional images and quantitative analysis of retinal features to optimize the diagnosis and monitoring of retinal disease and for enhanced pre- and post-therapy assessment. The device is beneficial for evaluation of cataract patients, pre- and post-operatively, and for the assessment of early signs of glaucoma and glaucomatous change.
- Stratus OCT™ - The proven standard of care OCT system for comprehensive retina and glaucoma management.
- Carl Zeiss Meditec, Inc.
- Get quote
- Bring the proven OCT to your practice. Featured in over 1,000 published clinical papers. Over 9,000 systems installed worldwide.
- See the virtual histology of retinal disease. Cross-sectional images and maps reveal the details of retinal abnormalities that are otherwise difficult to see.
- Determine and monitor retinal causes of poor visual acuity. Assess pre-op cataract and refractive patients to detect and document retinal disease and set expectations for visual outcomes.
- Assess glaucoma and track change. Evaluate RNFL and optic nerve head for glaucomatous damage. Identify and monitor patients who experience change in RNFL thickness with GPA™ Advanced Serial Analysis.
- Review results anywhere. Use full analysis capabilities from the lane, your office or a remote location with Stratus review software.
- Low-coherence interferometry: The Stratus OCT instrument scans an 820nm near infrared light beam from a superluminescent diode across the retina and generates a cross-sectional image of the tissue by recording the scattering profile versus depth of each transverse location of the beam.